Notice of Interim Results & Investor Presentation

Summary by AI BETAClose X

Ondine Biomedical Inc. will release its unaudited interim financial results for the period ending June 30, 2025, on September 26, 2025. A live presentation regarding these Half Year Results will be given by the President and Interim Chief Financial Officer via Investor Meet Company on the same day at 16:30 BST. The company encourages existing and potential shareholders to participate, with questions accepted before and during the event until September 25, 2025, at 09:00 BST. Interested parties can register for free on the Investor Meet Company platform to access the presentation.

Disclaimer*

UK 100

Latest directors dealings